Literature DB >> 11805063

Molecular characterization of the mouse In(10)17Rk inversion and identification of a novel muscle-specific gene at the proximal breakpoint.

Kathleen F Benson1, Kiran Chada.   

Abstract

Chromosomal rearrangements provide an important resource for molecular characterization of mutations in the mouse. In(10)17Rk mice contain a paracentric inversion of approximately 50 Mb on chromosome 10. Homozygous In(10)17Rk mice exhibit a pygmy phenotype, suggesting that the distal inversion breakpoint is within the pygmy locus. The pygmy mutation, originally isolated in 1944, is an autosomal recessive trait causing a dwarf phenotype in homozygous mice and has been mapped to the distal region of chromosome 10. The pygmy phenotype has subsequently been shown to result from disruption of the Hmgi-c gene. To identify the In(10)17Rk distal inversion breakpoint, In(10)17Rk DNA was subjected to RFLP analysis with single copy sequences derived from the wild-type pygmy locus. This analysis localized the In(10)17Rk distal inversion breakpoint to intron 3 of Hmgi-c and further study determined that a fusion transcript between novel 5' sequence and exons 4 and 5 of Hmgi-c is created. We employed 5' RACE to isolate the 5' end of the fusion transcript and this sequence was localized to the proximal end of chromosome 10 between markers Cni-rs2 and Mtap7. Northern blot analysis of individual tissues of wild-type mice determined that the gene at the In(10)17Rk proximal inversion breakpoint is a novel muscle-specific gene and its disruption does not lead to a readily observable phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805063      PMCID: PMC1461926     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  29 in total

1.  MDP77: A novel neurite-outgrowth-promoting protein predominantly expressed in chick muscles.

Authors:  A Uyeda; I Fukui; K Fujimori; K Kiyosue; H Nishimune; M Kasai; T Taguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

2.  Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy.

Authors:  J Finsterer; E Gharehbaghi-Schnell; C Stöllberger; K Fheodoroff; A Seiser
Journal:  Clin Genet       Date:  2001-05       Impact factor: 4.438

Review 3.  Molecular mechanisms for constitutional chromosomal rearrangements in humans.

Authors:  L G Shaffer; J R Lupski
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

4.  The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.

Authors:  A N Ladd; N Charlet; T A Cooper
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Northern blot normalization with a 28S rRNA oligonucleotide probe.

Authors:  V Barbu; F Dautry
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

6.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

7.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

9.  Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24.

Authors:  J Schönberger; H Levy; E Grünig; S Sangwatanaroj; D Fatkin; C MacRae; H Stäcker; C Halpin; R Eavey; E F Philbin; H Katus; J G Seidman; C E Seidman
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.